ReviewJournal of the American College of Cardiology2022
Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review.
Review in Journal of the American College of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
40 citing papers in PubMed, 201 citations in OpenAlex.
- Trends and disparities in ischemic heart disease and cardiogenic shock mortality in the United States: A 25-year national analysis (1999-2024).American heart journal plus : cardiology research and practice · 2026Article
- Combining external placebo-arm data in a prevention trial: effects of cocoa extract supplementation on cardiovascular disease.European journal of epidemiology · 2026Article
- Mortality After Cardiovascular Surgery and Procedures During the COVID-19 Pandemic in Ontario, Canada: A Retrospective Cohort Study.CJC open · 2026Article
- Trends in cardiovascular mortality among disaggregated Asian American subgroups: 2018-2022.American journal of preventive cardiology · 2026Article
- Burden of Ischemic Heart Disease in Central Asia from 1990 to 2021: A Systematic Analysis of the Global Burden of Disease Study 2021.International journal of environmental research and public health · 2026Article
- Methamphetamine Use Among Adult Patients Presenting With Acute Coronary Syndrome: A Single-Center Retrospective Cohort Study.Journal of the American Heart Association · 2026Article
- Impact of the COVID-19 Pandemic on Coronary Heart Disease Admissions and Mortality in Mexico: An Ecological Study.Health science reports · 2026Article
- Bereavement and Risk of Cardiovascular Disease Before and During the COVID-19 Pandemic.JAMA network open · 2026Article
- Mortality trends involving fatal-arrhythmias and anemia in the United States: A retrospective analysis of 25 years.Medicine · 2026Observational
- Comparing the "Life's Essential 8" Scores of Older Adults Living With Cardiovascular Diseases: NHANES, 2013 to 2018.Journal of the American Heart Association · 2025Article
- Trends in smoking-attributable cardiovascular mortality in Germany.European journal of public health · 2025Article
- Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine.JAMA neurology · 2025Article
- Nationwide Cross-Sectional Analysis of Mortality Trends in Patients with Sarcoidosis and Non-Ischemic Cardiovascular Disease-The Impact of Gender, Ethnicity, Geographical Location, and COVID-19 Pandemic.Journal of clinical medicine · 2024Article
- Inter- and intra-examiner reliability of short-term measurement of heart rate variability on rest in patients hospitalized with COVID-19.Scientific reports · 2024Article
- Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study.Korean circulation journal · 2024Article
- Impact of the COVID-19 pandemic on initiation of antihypertensive drugs in Sweden: an interrupted time series study.BMJ open · 2024Article
- Cause-specific excess mortality in Denmark, Finland, Norway, and Sweden during the COVID-19 pandemic 2020-2022: a study using nationwide population data.European journal of epidemiology · 2024Article
- A nationwide, population-based study on specialized care for acute heart failure throughout the COVID-19 pandemic.European journal of heart failure · 2024Article
- University students in Central Italy: do they follow proper dietary habits?Journal of preventive medicine and hygiene · 2024Article
- Rethinking patient flows in a changing healthcare system: a unified approach.Journal of preventive medicine and hygiene · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The impact of COVID-19 on the burden of cardiovascular diseases (CVD) during the early pandemic remains unclear. COVID-19 has become one of the leading causes of global mortality, with a disproportionate impact on persons with CVD. Studies of health facility admissions for CVD found significant decreases during the pandemic. Studies of hospital mortality for CVD were more variable. Studies of population-level CVD mortality differed across countries, with most showing decreases, although some revealed increases in deaths. In some countries where large increases in CVD deaths were reported in vital registration systems, misclassification of COVID-19 as CVD may have occurred. Taken together, studies suggest heterogeneous effects of the COVID-19 pandemic on CVD without large increases in CVD mortality in 2020 for a number of countries. Clinical and population science research is needed to examine the ways in which the pandemic has affected CVD burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.